Monocarboxylate transporters in physiology and cancer: from fundamentals to clinical translation
Physiological Reviews · 01.01.2027 · 107 (1) · 127-233
DOI: 10.1152/physrev.00004.2026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Physiological Reviews, erschienen am 01.01.2027. Verfasst von Julieta Afonso und 5 weiteren Autor:innen. Beteiligte Einrichtung: Life and Health Sciences Research Institute (ICVS), University of Minho, Campus of Gualtar, Braga, Portugal. Hauptthemen laut MEDLINE: Monocarboxylic Acid Transporters, Neoplasms. Die Arbeit nennt 868 Literaturangaben. Gefördert von: MEC | Fundação para a Ciência e a Tecnologia (FCT), EC | European Regional Development Fund (ERDF), Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (National Council for Scientific and Technologic….
Abstract (Originalsprache)
Monocarboxylate transporters (MCTs) are vital to physiological pH regulation, redox balance, and energy homeostasis, as they mediate proton-coupled transport of lactate and other monocarboxylates across cell membranes. MCT1 and MCT4 are especially important during metabolically demanding states, where they support lactate shuttling between oxidative and glycolytic cells. To sustain rapid growth and biosynthesis, the metabolism of highly proliferative cells, including cancer cells, shifts toward glycolysis with increased lactate production. In this setting, MCTs enable lactate and proton efflux, preventing intracellular acidification and maintaining glycolytic flux. Cancer cells frequently co-opt this system, overexpressing MCT1 and MCT4, which is associated with aggressive behavior, poor prognosis, and treatment resistance. These insights have motivated the development of MCT inhibitors, one of which has entered early clinical evaluation, suggesting potential therapeutic benefit in selected tumors. This review first introduces core aspects of cellular metabolism and then outlines the physiological roles, regulation, and tissue distribution of MCTs in normal tissues. It next examines how MCTs are dysregulated across cancer types to support the glycolytic phenotype, remodel the tumor microenvironment, and drive malignant progression, with particular focus on the prognostic impact of MCT expression. The article summarizes evidence linking MCT overexpression to poor outcomes and therapy resistance, and surveys efforts to therapeutically target MCTs and key translational barriers. Finally, it highlights future directions for exploiting MCT biology in precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Life and Health Sciences Research Institute (ICVS), University of Minho, Campus of Gualtar, Braga, Portugal.
- ICVS/Biomaterials, Biodegradables and Biomimetics (3B's)-Portuguese (PT) Government Associate Laboratory, Braga, Portugal.
- Cancer Biology and Epigenetics Group, IPO Porto Research Center (CI-IPO Porto), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
- RISE Associate Laboratory (Health Research Network), Porto, Portugal.
- Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), Porto, Portugal.
- Department of Pathology and Molecular Immunology, ICBAS-School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.
ORCID-Profile: Julieta Afonso, Fátima Baltazar
Förderung
- MEC | Fundação para a Ciência e a Tecnologia (FCT)
- EC | European Regional Development Fund (ERDF)
- Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (National Council for Scientific and Technologic…
- Portuguese Cancer League - North Branch
- ICVS - Life and Health Sciences Research Institute
- Centro de Investigação do IPO do Porto
- Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Afonso, J., Pereira-Vieira, J., Miranda-Gonçalves, V., Granja, S., Pinheiro, C., & Baltazar, F. (2027). Monocarboxylate transporters in physiology and cancer: from fundamentals to clinical translation. Physiological Reviews, 107(1), 127-233. https://doi.org/10.1152/physrev.00004.2026
Vancouver
Afonso J, Pereira-Vieira J, Miranda-Gonçalves V, Granja S, Pinheiro C, Baltazar F. Monocarboxylate transporters in physiology and cancer: from fundamentals to clinical translation. Physiological Reviews. 2027;107(1):127-233. doi:10.1152/physrev.00004.2026
BibTeX
@article{Afonso2027,
author = {Afonso, Julieta and Pereira-Vieira, Joana and Miranda-Gonçalves, Vera and Granja, Sara and Pinheiro, Céline and Baltazar, Fátima},
title = {Monocarboxylate transporters in physiology and cancer: from fundamentals to clinical translation},
journal = {Physiological Reviews},
year = {2027},
volume = {107},
number = {1},
pages = {127--233},
doi = {10.1152/physrev.00004.2026}
}
EUVIMED